Thomas K. Equels - Dec 13, 2021 Form 4/A - Amendment Insider Report for AIM ImmunoTech Inc. (AIM)

Role
CEO & President, Director
Signature
Thomas K. Equels
Stock symbol
AIM
Transactions as of
Dec 13, 2021
Transactions value $
$25,000
Form type
4/A - Amendment
Date filed
12/13/2021, 10:43 AM
Date Of Original Report
Dec 13, 2021
Previous filing
Dec 10, 2021
Next filing
Mar 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AIM Common Stock Award $25K +21.6K +7.72% $1.16 301K Dec 13, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Form amended to include reporting person is a director and officer.